Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy

Translational Oncology

Volumn 5, Issue 4, 2012, Pages 238-246

  Falou, Omar ^a,b   Soliman, Hany ^a   Sadeghi Naini, Ali ^a,b   Iradji, Sara ^b   Lemon Wong, Sharon ^a   Zubovits, Judit ^a   Spayne, Jacqueline ^a   Dent, Rebecca ^a   Trudeau, Maureen ^a   Boileau, Jean Francois ^a   Wright, Frances C ^a   Yaffe, Martin J ^a,b   Czarnota, Gregory J ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; HEMOGLOBIN; PAMIDRONIC ACID; SUNITINIB; TRASTUZUMAB;

ADULT; ADVANCED CANCER; ARTICLE; BIOCHEMICAL COMPOSITION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CLINICAL ARTICLE; DIFFUSE OPTICAL SPECTROSCOPY; DRUG MONITORING; FEMALE; HEMOGLOBIN DETERMINATION; HISTOLOGY; HUMAN; MASTECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME;

EID: 84865458423     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.11346     Document Type: Article

References (31)

1. American Cancer Society (2011). Cancer Facts and Figures. American Cancer Society, Atlanta, GA.
2. Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, and Cristofanilli M (2011). Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study. Cancer 117, 1819-1826.
3. Therasse P, Mauriac L, Welnicka-Jaskiewicz M, Bruning P, Cufer T, Bonnefoi H, Tomiak E, Pritchard KI, Hamilton A, Piccart MJ, et al. (2003). Final results of a randomized phase III trial comparing cyclophosphamide, epimbicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter study. J Clin Oncol 21, 843-850.
4. Esteva FJ and Hortobagyi GN (1999). Locally advanced breast cancer. Hematol Oncol Clin North Am 13, 457-472, vii.
5. De Lena M, Varini M, Zucali R, Rovini D, Viganotti G, Valagussa P, Veronesi U, and Bonadonna G (1981). Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. Cancer Clin Trials 4, 229-236.
6. Hortobagyi GN (1990). Comprehensive management of locally advanced breast cancer. Cancer 66, 1387-1391.
7. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, et al. (1998). Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16, 2672-2685.
8. Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian-Smith D, Moy L, Halpern E, Moore R, Kuter I, and Taghian A (2005). Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184, 868-877.
9. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, and Sickles E (1999). Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17, 110-119.
10. Belli P, Costantini M, Malaspina C, Magistrelli A, Latorre G, and Bonomo L (2006). MRI accuracy in residual disease evaluation in breast cancer patients treated with neoadjuvant chemotherapy. Clin Radiol 61, 946-953.
11. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, and Hylton NM (2002). Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179, 1193-1199.
12. 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study. Eur J Nucl Med 28, 711-720.
13. Ntziachristos V and Chance B (2001). Probing physiology and molecular function using optical imaging: applications to breast cancer. Breast Cancer Res 3, 41-46.
14. Tromberg BJ, Shah N, Lanning R, Cerussi A, Espinoza J, Pham T, Svaasand L, and Butler J (2000). Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2, 26-40.
15. Cerussi A, Hsiang D, Shah N, Mehta R, Durkin A, Butler J, and Tromberg BJ (2007). Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci USA 104, 4014-4019.
16. Shah N, Gibbs J, Wolverton D, Cerussi A, Hylton N, and Tromberg BJ (2005). Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study. J Biomed Opt 10, 051503.
17. Holboke MJ, Tromberg BJ, Li X, Shah N, Fishkin J, Kidney D, Butler J, Chance B, and Yodh AG (2000). Three-dimensional diffuse optical mammography with ultrasound localization in a human subject. J Biomed Opt 5, 237-247.
18. Shah N, Cerussi A, Eker C, Espinoza J, Butler J, Fishkin J, Hornung R, and Tromberg B (2001). Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci USA 98, 4420-4425.
19. Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, and Mehta R (2005). Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res 7, 279-285.
20. Zonios G, Perelman LT, Backman V, Manoharan R, Fitzmaurice M, Van Dam J, and Feld MS (1999). Diffuse reflectance spectroscopy of human adenomatous colon polyps in vivo. Appl Opt 38, 6628-6637.
21. Teicher BA (1994). Hypoxia and drug resistance. Cancer Metastasis Rev 13, 139-168.
22. Vaupel P and Hockel M (2000). Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. Int J Oncol 17, 869-879.
23. Choe R, Corlu A, Lee K, Durduran T, Konecky SD, Grosicka-Koptyra M, Arridge SR, Czerniecki BJ, Fraker DL, DeMichele A, et al. (2005). Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys 32, 1128-1139.
24. Jakubowski DB, Cerussi AE, Bevilacqua F, Shah N, Hsiang D, Butler J, and Tromberg BJ (2004). Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study. J Biomed Opt 9, 230-238.
25. Soliman H, Gunasekara A, Rycroft M, Zubovits J, Dent R, Spayne J, Yaffe MJ, and Czarnota GJ (2010). Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer. Clin Cancer Res 16, 2605-2614.
26. Zhou C, Choe R, Shah N, Durduran T, Yu G, Durkin A, Hsiang D, Mehta R, Butler J, Cerussi A, et al. (2007). Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy. J Biomed Opt 12, 051903.
27. Clarke GM, Eidt S, Sun L, Mawdsley G, Zubovits JT, and Yaffe MJ (2007). Whole-specimen histopathology: a method to produce whole-mount breast serial sections for 3-D digital histopathology imaging. Histopathology 50, 232-242.
28. Roblyer D, Ueda S, Cerussi A, Tanamai W, Durkin A, Mehta R, Hsiang D, Butler JA, McLaren C, Chen WP, et al. (2011). Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment. Proc Natl Acad Sci USA 108, 14626-14631.
29. Khayat M, Ichalalene Z, Mincu N, Leblond F, Guilman O, and Djeziri S (2007). Optical tomography as adjunct to x-ray mammography: methods and results. In Multimodal Biomedical Imaging II. FS Azar (Ed.) SPIE-The International Society for Optical Engineering, San Jose, CA. pp. 64310E-1-64310F-12.
30. Mincu N, Djeziri S, Ichalalene Z, Leblond F, and Khayat M (2007). Sensitivity and repeatability of diffuse optical tomography: towards breast cancer neo-adjuvant treatment monitoring. In Optical Tomography and Spectroscopy of Tissue VII B Chance, RR Alfano, BJ Tromberg, M Tamura, and EM Sevick-Muraca (Eds). Proceedings of SPIE-The International Society for Optical Engineering, San Jose, CA. pp. 64341D-1-64341D-9.
31. Tromberg BJ and Cerussi AE (2010). Imaging breast cancer chemotherapy response with light. Commentary on Soliman et al., p. 2605. Clin Cancer Res 16, 2486-2488.